Simcyp, now part of Certara, is pleased to announce the release of Version 12 of its Population-based Simulator, the pharmaceutical industry’s most sophisticated ...

PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the global biosimulation technology-enabled drug development company, today announced the release of version 15 of its Simcyp® Population-based Simulator.

Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced the launch of version 18 of its Simcyp Population-based ...

An accurate method to simulate prehistoric movements of people based upon current topographical satellite data may prove useful in determining early human population dynamics even when no genetic ...

A “Validated” column in the DDI perpetrator table to clearly identify the values that have been validated by our DDI experts for use in simulations Dr. Michael Bolger, Founding Scientist of Simulation ...

PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced ...

Certara, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has announced the released of version 16 of its ...